VANCOUVER, BC, Aug. 15, 2023 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO:FH) (FSE:7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development company, released its first quarter financial results and operational highlights for the period ended June 30, 2023.
Read more at newswire.caFILAMENT HEALTH ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS AND REFILES Q1 2023 INTERIM FINANCIAL STATEMENTS AND MD&A
Newswire.ca - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here